Cargando…

Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review

BACKGROUND: The patient experience of multiple myeloma (MM) is multifaceted and varies substantially between individuals. Current published information on the patient perspective and treatment of MM is limited, making it difficult to gain insights into patient needs regarding the condition. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyall, Matthew, Crawford, Rebecca, Bell, Timothy, Mamolo, Carla, Neuhof, Alexander, Levy, Courtney, Heyes, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539647/ https://www.ncbi.nlm.nih.gov/pubmed/36136395 http://dx.doi.org/10.2196/39068

Ejemplares similares

Response rates and minimal residual disease outcomes as potential surrogates for progression-free survival in newly diagnosed multiple myeloma
por: Daniele, Patrick, et al.
Publicado: (2022)

Bispecific antibodies in multiple myeloma treatment: A journey in progress
por: Cho, Shih-Feng, et al.
Publicado: (2022)

Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials
por: Costello, Jessica, et al.
Publicado: (2019)

Multiple Myeloma
por: Crawford, A. Muir
Publicado: (1933)

The role of CXCR4 in multiple myeloma: Cells’ journey from bone marrow to beyond
por: Ullah, Tomalika Rahmat
Publicado: (2019)

A Journey through the Inter-Cellular Interactions in the Bone Marrow in Multiple Myeloma: Implications for the Next Generation of Treatments
por: Hervás-Salcedo, Rosario, et al.
Publicado: (2022)

Comprehensive characterization of the epigenetic landscape in Multiple Myeloma
por: Alaterre, Elina, et al.
Publicado: (2022)

The long journey of stem cell therapeutics
por: Crawford, Sarah
Publicado: (2012)

Alpha-2 HS glycoprotein in the hypercalcaemia of multiple myeloma.
por: Crawford, S. M.
Publicado: (1984)

Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan
por: Liu, Yanfang, et al.
Publicado: (2021)

Impact of COVID-19 on the stroke rehabilitation pathway: multidisciplinary team reflections on a patient and carer journey from acute to community stroke services
por: Lucas, Lauren, et al.
Publicado: (2021)

Trust and shared decision‐making among individuals with multiple myeloma: A qualitative study
por: Whitney, Robin L., et al.
Publicado: (2021)

A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity
por: Da Vià, Matteo C., et al.
Publicado: (2020)

Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK
por: Russell-Smith, T. Alexander, et al.
Publicado: (2021)

The Genetic Architecture of Multiple Myeloma
por: Prideaux, Steven M., et al.
Publicado: (2014)

Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma
por: Zhang, Liangxuan, et al.
Publicado: (2016)

Characterization of rare germline variants in familial multiple myeloma
por: Catalano, Calogerina, et al.
Publicado: (2021)

Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study
por: Janssens, Rosanne, et al.
Publicado: (2021)

Multiple myeloma: an overview of management
por: Bird, Sarah Anne, et al.
Publicado: (2019)

Journeys to HIV testing and diagnosis among adults aged 50+ years in England: A qualitative interview study
por: Bell, Sadie, et al.
Publicado: (2020)

Assessing contraceptive use as a continuum: outcomes of a qualitative assessment of the contraceptive journey
por: Simmons, Rebecca G., et al.
Publicado: (2023)

Journey to vaccination: a protocol for a multinational qualitative study
por: Wheelock, Ana, et al.
Publicado: (2014)

Journey of Nursing in COVID-19 Crisis: A Qualitative Study
por: Monjazebi, Fatemeh, et al.
Publicado: (2021)

Qualitative Interdisciplinary Learning Reviews of Non-COVID-19 Patients’ Journeys During the COVID-19 Pandemic
por: Kwok, Matthew Mo Kin, et al.
Publicado: (2021)

Primary lesion of multiple myeloma presenting as gingival swelling
por: DaBell, Michael, et al.
Publicado: (2012)

Multiple myeloma
por: Collins, Conor D
Publicado: (2004)

Multiple myeloma
por: Collins, Conor D.
Publicado: (2010)

Multiple Myeloma
por: Mandelli, F
Publicado: (1995)

Multiple Myeloma
por: Shennan, Theodore
Publicado: (1913)

Multiple Myeloma
por: Shennan, Theodore
Publicado: (1913)

Multiple Myeloma
por: Parker, D., et al.
Publicado: (1979)

Multiple Myeloma
Publicado: (2019)

Multiple myeloma
por: Delforge, Michel
Publicado: (2018)

Characterization of the role of Samsn1 loss in multiple myeloma development
por: Friend, Natasha L., et al.
Publicado: (2020)

Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells
por: Guo, Wancheng, et al.
Publicado: (2021)

Genomic characterization of functional high-risk multiple myeloma patients
por: Soekojo, Cinnie Yentia, et al.
Publicado: (2022)

PB1969: FUNCTIONAL CHARACTERIZATION OF SUSCEPTIBILITY LOCI TO MULTIPLE MYELOMA
por: Shokouhi, M., et al.
Publicado: (2022)

Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance
por: Mejia Saldarriaga, Mateo, et al.
Publicado: (2022)

P800: CHARACTERIZATION OF REGULATORY T CELLS IN PATIENTS WITH MULTIPLE MYELOMA
por: Kim, Sojeong, et al.
Publicado: (2023)

Meningeal involvement in multiple myeloma
por: Laribi, Kamel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u6qmulfd2iqfg8rdl3bfc193t7